Retatrutide is a next-generation peptide designed to support weight loss and metabolic health. By activating three key receptors—GLP-1, GIP, and glucagon—it goes beyond the dual- and single-receptor mechanisms of tirzepatide and semaglutide. This triple-receptor approach promotes greater appetite suppression, enhanced fat burning, improved glucose control, and higher energy expenditure, making Retatrutide one of the most promising metabolic therapies available today.
Retatrutide is a next-generation triple-receptor peptide (GLP-1, GIP, and glucagon) developed to maximize weight loss, improve metabolic function, and increase energy expenditure beyond the capabilities of semaglutide and tirzepatide.
| ACTIVE HALF-LIFE | |
| CLASSIFICATION | Investigational Drug / Peptide |
| DOSAGE | |
| ACNE | |
| WATER RETENTION | |
| HBR | |
| HEPATOTOXICITY | |
| AROMATIZATION |
Stay Up to Date with All News and Exclusive Offers
Decentralized Shipping
US Domestic and
International delivery
Orders Insurance
Free and easy reships
of lost parcels
Online Support
24 hours a day
7 days a week
Flexible Payment
Pay with Credit Cards
Zelle and Crypto Coins